Global Liquid Biopsy Market by Clinical Application, Therapeutic Application, Biomarker Type, Analysis Platform, Analysis Purpose, Product, Industry Verticals, and Geography

Global Liquid Biopsy Market Projected to Reach $4.75 Billion by 2028, Rising at a CAGR of 18.54%

The global market for liquid biopsy is evaluated to register tremendous growth at a CAGR of 18.54% during the considered phase of 2021-2028.

With age, the body’s immune system tends to deteriorate. Thus, people above 60 years are susceptible to chronic diseases, such as cancer. Over the year, there has been a significant rise in the number of aged people suffering from breast and colorectal cancer. Hence, the high prevalence of cancer among the geriatric population increases the need for liquid biopsy, thereby driving the liquid biopsy market’s development.

Furthermore, the technological advancements and rising demand for diagnostics centers are opening new avenues for the studied market. However, the dearth of skilled professionals, coupled with the high cost of liquid biopsy tests, hinders the overall market’s growth.

REGIONAL OUTLOOK

The global liquid biopsy market covers the Asia-Pacific, North America, Latin America, Europe, and the Middle East and Africa regions.
The Asia-Pacific is estimated to become the fastest evolving region in the liquid biopsy market over the projected phase 2021-2028. The region provides several lucrative opportunities to the studied market to attain the anticipated growth during the given period. Additionally, the high population base in countries such as India and China is estimated to boost the demand for liquid biopsy in the upcoming years. Other than this, the surge in healthcare spending, along with the rise in awareness regarding the use of liquid biopsy, is motivating the expansion of the liquid biopsy market within the APAC region.

COMPETITIVE OUTLOOK

The renowned companies thriving in the liquid biopsy market are Menarini-Silicon Biosystems, Qiagen NV, Biocept Inc, Illumina Inc, Myriad Genetics Inc, Bio-Rad Laboratories Inc, Guardant Health Inc, Foundation Medicine, Personal Genome Diagnostics, Agilent Technologies Inc, Thermo Fisher Scientific Inc, Adaptive Biotechnologies, MDxHealth SA, Grail, Becton Dickinson and Company (BD), Angle Plc, F Hoffmann-La Roche, and Natera.
Agilent Technologies Inc provides instruments, software, services, and consumable solutions to analyze, detect, and quantify the biological and physical properties of substances and products. The company offers its products and services to several sectors, including chemical, environmental, forensics, clinical, and diagnostics. Founded in 1999, it markets its products via direct sales, resellers, distributors, and representatives. Agilent has manufacturing facilities, along with R&D centers globally, with headquarters located in California, the United States.

Frequently Asked Questions about the Global Liquid Biopsy Market

What is the estimated value of the Global Liquid Biopsy Market?

The Global Liquid Biopsy Market was estimated to be valued at $1179.1 Million in 2020.

What is the growth rate of the Global Liquid Biopsy Market?

The growth rate of the Global Liquid Biopsy Market is 19.1%, with an estimated value of $4759 Million by 2028.

What is the forecasted size of the Global Liquid Biopsy Market?

The Global Liquid Biopsy Market is estimated to be worth $4759 Million by 2028.

Who are the key companies in the Global Liquid Biopsy Market?

Key companies in the Global Liquid Biopsy Market include Adaptive Biotechnologies, Agilent Technologies Inc., Angle plc, Becton Dickinson and Company (BD), Bio, Rad Laboratories Inc., Biocept Inc., F Hoffmann, La Roche and Foundation Medicine.

Report Attribute	Details
No. of Pages	270
Published	May 2021
Forecast Period	2020 - 2028
Estimated Market Value ( USD ) in 2020	$ 1179.1 Million
Forecasted Market Value ( USD ) by 2028	$ 4759 Million
Compound Annual Growth Rate	19.1%
Regions Covered	Global

1. Global Liquid Biopsy Market - Summary

2. Industry Outlook
2.1. Impact of COVID-19 on Liquid Biopsy Market
2.2. Key Insights
2.3. Porter’s Five Forces Model
2.3.1. Threat of New Entrants
2.3.2. Threat of Substitute Products
2.3.3. Bargaining Power of Buyers
2.3.4. Bargaining Power of Suppliers
2.3.5. Competitive Rivalry
2.4. Initiatives Pertaining to Liquid Biopsy
2.5. Legal, Policy, & Regulatory Framework
2.6. Market Attractiveness Index
2.7. Vendor Scorecard
2.8. Key Market Strategies
2.8.1. Contracts and Partnership
2.8.2. Business Expansion, Announcements, and Divestitures
2.8.3. Acquisitions & Mergers
2.8.4. New Product Launches
2.9. Market Drivers
2.9.1. High Prevalence of Cancer in Geriatric Population
2.9.2. Growing Importance of Liquid Biopsy Testing
2.9.3. Rising Government Initiatives
2.10. Market Restraints
2.10.1. Lack of Reimbursement for Liquid Biopsy
2.10.2. Disadvantages Associated with Compensation
2.10.3. Unavailability of Skilled Professionals
2.10.4. High Cost of Liquid Biopsy Test
2.11. Market Opportunities
2.11.1. Advancement in Technologies
2.11.2. Untapped Diagnostic Testing Opportunities in Developing Countries
2.11.3. Growing Demand for Diagnostic Centers

3. Global Liquid Biopsy Market - by Clinical Application
3.1. Treatment Monitoring
3.2. Prognosis and Reoccurrence Monitoring
3.3. Treatment Selection
3.4. Diagnosis and Screening

4. Global Liquid Biopsy Market - by Therapeutic Application
4.1. Lung Cancer
4.2. Breast Cancer
4.3. Prostate Cancer
4.4. Colorectal Cancer
4.5. Melanoma Cancer
4.6. Other Types of Cancer
4.7. Non-Oncology Application

5. Global Liquid Biopsy Market - by Biomarker Type
5.1. Nucleic Acid
5.2. Protein
5.3. Extracellular Vesicles
5.4. Cells

6. Global Liquid Biopsy Market - by Analysis Platform
6.1. NGS
6.2. Microarray
6.3. PCR
6.4. Proteomics
6.5. Other Analysis Platforms

7. Global Liquid Biopsy Market - by Analysis Purpose
7.1. Early Detection/Screening
7.2. Therapy Guidance
7.3. Monitoring
7.4. Diagnosis

8. Global Liquid Biopsy Market - by Product
8.1. Circulating Tumor DNA (CTDNA)
8.2. Circulating Tumor Cells (CTCS)
8.3. Cell-Free DNA (CFDNA)
8.4. Extracellular Vesicles and Others

9. Global Liquid Biopsy Market - by Industry Verticals
9.1. Physicians’ Office Laboratories
9.2. Hospitals
9.3. Clinical Diagnostic Laboratories

10. Global Liquid Biopsy Market - Regional Outlook
10.1. North America
10.1.1. Country Analysis
10.1.1.1. United States
10.1.1.2. Canada
10.2. Europe
10.2.1. Country Analysis
10.2.1.1. United Kingdom
10.2.1.2. France
10.2.1.3. Germany
10.2.1.4. Italy
10.2.1.5. Russia
10.2.1.6. Spain
10.2.1.7. Rest of Europe
10.3. Asia-Pacific
10.3.1. Country Analysis
10.3.1.1. Japan
10.3.1.2. China
10.3.1.3. India
10.3.1.4. South Korea
10.3.1.5. Australia & New Zealand
10.3.1.6. ASEAN Countries
10.3.1.7. Rest of Asia-Pacific
10.4. Latin America
10.4.1. Country Analysis
10.4.1.1. Brazil
10.4.1.2. Mexico
10.4.1.3. Rest of Latin America
10.5. Middle East and Africa
10.5.1. Country Analysis
10.5.1.1. Saudi Arabia
10.5.1.2. United Arab Emirates
10.5.1.3. Turkey
10.5.1.4. South Africa
10.5.1.5. Rest of Middle East & Africa

11. Competitive Landscape
11.1. Adaptive Biotechnologies
11.2. Agilent Technologies Inc.
11.3. Angle plc
11.4. Becton Dickinson and Company (BD)
11.5. Biocept Inc.
11.6. Bio-Rad Laboratories Inc.
11.7. F Hoffmann-La Roche
11.8. Foundation Medicine
11.9. Grail
11.10. Guardant Health Inc.
11.11. Illumina Inc.
11.12. MDxHealth SA
11.13. Menarini-Silicon Biosystems
11.14. Myriad Genetics Inc.
11.15. Natera
11.16. Personal Genome Diagnostics
11.17. Qiagen N.V.
11.18. Thermo Fisher Scientific Inc.

12. Research Methodology & Scope
12.1. Research Scope & Deliverables
12.1.1. Objectives of Study
12.1.2. Scope of Study
12.2. Sources of Data
12.2.1. Primary Data Sources
12.2.2. Secondary Data Sources
12.3. Research Methodology
12.3.1. Evaluation of Proposed Market
12.3.2. Identification of Data Sources
12.3.3. Assessment of Market Determinants
12.3.4. Data Collection
12.3.5. Data Validation & Analysis

List of Tables
Table 1: Global Liquid Biopsy Market, by Region, 2021-2028 (In $ Million)
Table 2: Vendor Scorecard
Table 3: List of Contracts and Partnership
Table 4: List of Business Expansions, Announcements, and Divestitures
Table 5: List of Acquisitions & Mergers
Table 6: List of New Product Launches
Table 7: Government Initiatives Pertaining to Cancer and Liquid Biopsy in Some Countries
Table 8: Global Liquid Biopsy Market, by Clinical Application, 2021-2028 (In $ Million)
Table 9: Global Liquid Biopsy Market, by Therapeutic Application, 2021-2028 (In $ Million)
Table 10: Global Liquid Biopsy Market, by Biomarker Type, 2021-2028 (In $ Million)
Table 11: Global Liquid Biopsy Market, by Analysis Platform, 2021-2028 (In $ Million)
Table 12: Global Liquid Biopsy Market, by Analysis Purpose, 2021-2028 (In $ Million)
Table 13: Global Liquid Biopsy Market, by Product, 2021-2028 (In $ Million)
Table 14: Global Liquid Biopsy Market, by Industry Verticals, 2021-2028 (In $ Million)
Table 15: Global Liquid Biopsy Market, by Region, 2021-2028 (In $ Million)
Table 16: North America Liquid Biopsy Market, by Country, 2021-2028 (In $ Million)
Table 17: Europe Liquid Biopsy Market, by Country, 2021-2028 (In $ Million)
Table 18: Asia-Pacific Liquid Biopsy Market, by Country, 2021-2028 (In $ Million)
Table 19: Latin America Liquid Biopsy Market, by Country, 2021-2028 (In $ Million)
Table 20: Middle East and Africa Liquid Biopsy Market, by Country, 2021-2028 (In $ Million)

List of Figures
Figure 1: Global Liquid Biopsy Market, by Region, 2021-2028 (In $ Million)
Figure 2: Global Liquid Biopsy Market, by Clinical Application, 2020 & 2028 (In %)
Figure 3: Global Liquid Biopsy Market, by Treatment Monitoring, 2021-2028 (In $ Million)
Figure 4: Global Liquid Biopsy Market, by Prognosis and Reoccurrence Monitoring, 2021-2028 (In $ Million)
Figure 5: Global Liquid Biopsy Market, by Treatment Selection, 2021-2028 (In $ Million)
Figure 6: Global Liquid Biopsy Market, by Diagnosis and Screening, 2021-2028 (In $ Million)
Figure 7: Global Liquid Biopsy Market, by Therapeutic Application, 2020 & 2028 (In %)
Figure 8: Global Liquid Biopsy Market, by Lung Cancer, 2021-2028 (In $ Million)
Figure 9: Global Liquid Biopsy Market, by Breast Cancer, 2021-2028 (In $ Million)
Figure 10: Global Liquid Biopsy Market, by Prostate Cancer, 2021-2028 (In $ Million)
Figure 11: Global Liquid Biopsy Market, by Colorectal Cancer, 2021-2028 (In $ Million)
Figure 12: Global Liquid Biopsy Market, by Melanoma Cancer, 2021-2028 (In $ Million)
Figure 13: Global Liquid Biopsy Market, by Other Types of Cancer, 2021-2028 (In $ Million)
Figure 14: Global Liquid Biopsy Market, by Non-Oncology Application, 2021-2028 (In $ Million)
Figure 15: Global Liquid Biopsy Market, by Biomarker Type, 2020 & 2028 (In %)
Figure 16: Global Liquid Biopsy Market, by Nucleic Acid, 2021-2028 (In $ Million)
Figure 17: Global Liquid Biopsy Market, by Protein, 2021-2028 (In $ Million)
Figure 18: Global Liquid Biopsy Market, by Extracellular Vesicles, 2021-2028 (In $ Million)
Figure 19: Global Liquid Biopsy Market, by Cells, 2021-2028 (In $ Million)
Figure 20: Global Liquid Biopsy Market, by Analysis Platform, 2020 & 2028 (In %)
Figure 21: Global Liquid Biopsy Market, by NGS, 2021-2028 (In $ Million)
Figure 22: Global Liquid Biopsy Market, by Microarray, 2021-2028 (In $ Million)
Figure 23: Global Liquid Biopsy Market, by PCR, 2021-2028 (In $ Million)
Figure 24: Global Liquid Biopsy Market, by Proteomics, 2021-2028 (In $ Million)
Figure 25: Global Liquid Biopsy Market, by Other Analysis Platforms, 2021-2028 (In $ Million)
Figure 26: Global Liquid Biopsy Market, by Analysis Purpose, 2020 & 2028 (In %)
Figure 27: Global Liquid Biopsy Market, by Early Detection/Screening, 2021-2028 (In $ Million)
Figure 28: Global Liquid Biopsy Market, by Therapy Guidance, 2021-2028 (In $ Million)
Figure 29: Global Liquid Biopsy Market, by Monitoring, 2021-2028 (In $ Million)
Figure 30: Global Liquid Biopsy Market, by Diagnosis, 2021-2028 (In $ Million)
Figure 31: Global Liquid Biopsy Market, by Product, 2020 & 2028 (In %)
Figure 32: Global Liquid Biopsy Market, by Circulating Tumor DNA (CTDNA), 2021-2028 (In $ Million)
Figure 33: Global Liquid Biopsy Market, by Circulating Tumor Cells (CTCS), 2021-2028 (In $ Million)
Figure 34: Global Liquid Biopsy Market, by Cell-Free DNA (CFDNA), 2021-2028 (In $ Million)
Figure 35: Global Liquid Biopsy Market, by Extracellular Vesicles and Others, 2021-2028 (In $ Million)
Figure 36: Global Liquid Biopsy Market, by Industry Verticals, 2020 & 2028 (In %)
Figure 37: Global Liquid Biopsy Market, by Physicians’ Office Laboratories, 2021-2028 (In $ Million)
Figure 38: Global Liquid Biopsy Market, by Hospitals, 2021-2028 (In $ Million)
Figure 39: Global Liquid Biopsy Market, by Clinical Diagnostic Laboratories, 2021-2028 (In $ Million)
Figure 40: Global Liquid Biopsy Market, by Region, 2020 & 2028 (In %)
Figure 41: United States Liquid Biopsy Market 2021-2028 (In $ Million)
Figure 42: Canada Liquid Biopsy Market 2021-2028 (In $ Million)
Figure 43: United Kingdom Liquid Biopsy Market 2021-2028 (In $ Million)
Figure 44: France Liquid Biopsy Market 2021-2028 (In $ Million)
Figure 45: Germany Liquid Biopsy Market 2021-2028 (In $ Million)
Figure 46: Italy Liquid Biopsy Market 2021-2028 (In $ Million)
Figure 47: Russia Liquid Biopsy Market 2021-2028 (In $ Million)
Figure 48: Spain Liquid Biopsy Market 2021-2028 (In $ Million)
Figure 49: Rest of Europe Liquid Biopsy Market 2021-2028 (In $ Million)
Figure 50: Japan Liquid Biopsy Market 2021-2028 (In $ Million)
Figure 51: China Liquid Biopsy Market 2021-2028 (In $ Million)
Figure 52: India Liquid Biopsy Market 2021-2028 (In $ Million)
Figure 53: South Korea Liquid Biopsy Market 2021-2028 (In $ Million)
Figure 54: Australia & New Zealand Liquid Biopsy Market 2021-2028 (In $ Million)
Figure 55: ASEAN Countries Liquid Biopsy Market 2021-2028 (In $ Million)
Figure 56: Rest of Asia-Pacific Liquid Biopsy Market 2021-2028 (In $ Million)
Figure 57: Brazil Liquid Biopsy Market 2021-2028 (In $ Million)
Figure 58: Mexico Liquid Biopsy Market 2021-2028 (In $ Million)
Figure 59: Rest of Latin America Liquid Biopsy Market 2021-2028 (In $ Million)
Figure 60: Saudi Arabia Liquid Biopsy Market 2021-2028 (In $ Million)
Figure 61: United Arab Emirates Liquid Biopsy Market 2021-2028 (In $ Million)
Figure 62: Turkey Liquid Biopsy Market 2021-2028 (In $ Million)
Figure 63: South Africa Liquid Biopsy Market 2021-2028 (In $ Million)
Figure 64: Rest of Middle East & Africa Liquid Biopsy Market 2021-2028 (In $ Million)